Genomic Health, Inc. Announces Year-End 2012 Financial Results, Provides 2013 Financial Outlook
2/7/2013 7:04:32 AM
REDWOOD CITY, Calif., Feb. 6, 2013 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today reported financial results and business progress for the quarter and year ended December 31, 2012.
Total revenue for the fourth quarter of 2012 increased to $60.4 million, compared with $53.4 million in the fourth quarter of 2011. Product revenue was $60.0 million in the fourth quarter of 2012, compared with $53.2 million for the fourth quarter of 2011, an increase of 13 percent.